VYNE Therapeutics Inc (VYNE)
2.33
+0.08
(+3.56%)
USD |
NASDAQ |
Apr 22, 16:00
2.28
-0.05
(-2.15%)
After-Hours: 20:00
VYNE Therapeutics Total Liabilities (Quarterly): 8.95M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.95M |
| September 30, 2023 | 7.762M |
| June 30, 2023 | 7.687M |
| March 31, 2023 | 8.832M |
| December 31, 2022 | 9.556M |
| September 30, 2022 | 6.839M |
| June 30, 2022 | 6.835M |
| March 31, 2022 | 8.588M |
| December 31, 2021 | 18.41M |
| September 30, 2021 | 22.43M |
| June 30, 2021 | 59.09M |
| March 31, 2021 | 56.27M |
| December 31, 2020 | 56.25M |
| September 30, 2020 | 58.17M |
| Date | Value |
|---|---|
| June 30, 2020 | 59.31M |
| March 31, 2020 | 91.00M |
| December 31, 2019 | 10.66M |
| September 30, 2019 | 9.574M |
| June 30, 2019 | 12.21M |
| March 31, 2019 | 10.63M |
| December 31, 2018 | 9.551M |
| September 30, 2018 | 8.074M |
| June 30, 2018 | 8.727M |
| March 31, 2018 | 14.78M |
| December 31, 2017 | 123.90M |
| September 30, 2017 | 123.76M |
| December 31, 2016 | 71.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.835M
Minimum
Jun 2022
91.00M
Maximum
Mar 2020
27.29M
Average
10.66M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics Inc | 20.07M |
| AN2 Therapeutics Inc | 14.04M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.68M |
| Shareholders Equity (Quarterly) | 88.74M |
| Current Ratio | 12.73 |